MRVL stock · XGN stock

MRVL vs XGN · P/E 100, rev $5.16B vs rev $37.2M

Marvell Technology Group Ltd (MRVL) versus Exagen Inc (XGN) — a side-by-side from cached financials, not a winner call.

Marvell Technology Group Ltd (MRVL) is a semiconductors company listed on NASDAQ. It is led by Matthew J. Murphy.

Exagen Inc (XGN) is a diagnostics & research company listed on US.

Latest reported MRVL revenue for 2026-08-01 was $5.16B. Net income was $342.5M. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.

Latest reported XGN revenue for 2026-06-30 was $37.2M. Net income was -$7.2M. XGN currently screens at market cap $154.1M.

MRVL currently screens at market cap $253.51B and trailing P/E 99.8. XGN currently screens at market cap $154.1M.

Not investment advice. Open the MRVL and XGN stock pages for the full models.

Not investment advice.

Popular Stock Comparisons